acamprosate calcium (Zydus Pharmaceuticals (USA) Inc.)
Welcome to the PulseAid listing for the acamprosate calcium drug offered from Zydus Pharmaceuticals (USA) Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Zydus Pharmaceuticals (USA) Inc. |
| NON-PROPRIETARY NAME: | acamprosate calcium |
| SUBSTANCE NAME: | ACAMPROSATE CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-06-01 |
| END MARKETING DATE: | 0000-00-00 |
acamprosate calcium HUMAN PRESCRIPTION DRUG Details:
| Item Description | acamprosate calcium from Zydus Pharmaceuticals (USA) Inc. |
| LABELER NAME: | Zydus Pharmaceuticals (USA) Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 333(mg/1) |
| START MARKETING DATE: | 2017-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68382-569_fd2af2f5-8924-4fbb-bb50-c233640c33fa |
| PRODUCT NDC: | 68382-569 |
| APPLICATION NUMBER: | ANDA205995 |
Other ACAMPROSATE CALCIUM Pharmaceutical Manufacturers / Labelers:
